International Journal of Drug Development and Research

  • ISSN: 0975-9344
  • Journal h-index: 51
  • Journal CiteScore: 46.50
  • Journal Impact Factor: 26.99
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Euro Pub
  • Google Scholar
  • J-Gate
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page


Formulation Development and Evaluation of taste masked orally disintegrating tablets of Perindopril Erbumine by direct Compression method

Ratnaparkhi Mukesh P., Jagadale Sachin K., Patil Pradeep S. and Dhiwar Suresh B

The aim of the current study is to develop and evaluate patient friendly taste masked oro-dispersible tablets of Perindopril Erbumine. Perindopril is an antihypertensive drug and is used in the management of hypertensive urgency. The bitter taste of the drug and the fact that it being a pro-drug needs to be converted to active metabolite after being absorbed emphasizes on the need for improvement in patient compliance and improvement in disintegration time in order to enhance the onset of action. Taste masking is done by using polymethacrylate co-polymer by mass extrusion technique. The preliminary batches were prepared by using different superdisintegrants like Ac-Di-Sol, Primogel, Tulsion-335 and Tulsion-339. From the preliminary study it was found that orodispersible tablets containing Ac-Di-Sol showed better disintegration time and it was considered for further studies. A 32 full factorial design was applied to optimize the formulations, nine batches were prepared and evaluated. It was observed from the evaluations that the batch A2 showed the best disintegration time and also completes drug release within five minutes. Hence it was concluded that orally disintegrating tablets of Perindopril Erbumine can be successfully formulated using Ac-Di-Sol.